Song Seo, DPM
Foot & Ankle Surgery · Mahwah, NJNPI 1467869255
Payments from drug & device makers
What this record shows
This record is dominated by education: $1,148 of the $1,897 with a category attached, or 60.5%. Seapearl East, Inc accounts for 60.5% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2019 at $1,209 and has fallen 90.3% since, to $117 in 2024. That places this record below the midpoint for foot & ankle surgery clinicians in NJ, where the typical reported total is $1,926.
Across 21 payments — averaging $90.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Seapearl East, Inc$1K
- Stryker$405
- Treace Medical Concepts, Inc.$99
- Nevro Corp.$58
- Paratek Pharmaceuticals, Inc.$55
- Amgen$51
- plus $82 from 4 others
What the payments were for
- Travel & lodging$33718%
- Food & beverage$41222%
- Education$1,14861%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Seapearl East, Inc | 1 | $1,148 |
| Stryker | 5 | $405 |
| Treace Medical Concepts, Inc. | 3 | $99 |
| Nevro Corp. | 1 | $58 |
| Paratek Pharmaceuticals, Inc. | 4 | $55 |
| Amgen | 3 | $51 |
| Orthofix Medical, Inc. | 1 | $27 |
| Zimmer Biomet | 1 | $26 |
| Orpyx Medical Technologies US Inc. | 1 | $15 |
| Paragon 28, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SPINEJACK$337
How this compares
$1,897 in reported general payments places this provider in the 45th percentile of 542 foot & ankle surgery providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ciclopirox | 56 | $2,802 |
| Gentamicin Sulfate | 61 | $2,090 |
| CiclopiroxCiclopirox Olamine | 61 | $1,253 |
| Ketoconazole | 23 | $457 |
| Cephalexin | 23 | $115 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Mahwah
- John CozzarelliBelleville$932K
- Matthew RegulskiToms River$843K
- Michael SubikLyndhurst$529K
- Krupa PatelMorris Plains$281K
- Johanna GodoyWayne$254K
- Andrew BriefRidgewood$253K
- Mark SolomonCedar Knolls$232K
- Evan AdlerOld Bridge$195K
- Shane HollawellManasquan$169K
- Jacob ReinkrautRidgewood$80K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.